Jami McLaughlin
- Hematology top 0.5%
- Molecular Biology top 10%
- Genetics top 1%
- Immunology top 5%
- Oncology top 5%
- Co-authors
- Owen N. WitteDaniel AfarAndrei GogaCharles L. SawyersSteven S. ClarkWilliam M. CristCaius G. RaduIrvin S. Y. Chen
- Topics
- Chronic Myeloid Leukemia Treatments (17 papers)Chronic Lymphocytic Leukemia Research (8 papers)CAR-T cell therapy research (8 papers)
- Cited by
- HematologyGeneticsImmunology
- Partner nations
- United StatesAustraliaPoland
In The Last Decade
Jami McLaughlin
32 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 93
- Hematology 1.4k
- Molecular Biology 1.1k
- Genetics 768
- Immunology 546
- Oncology 523
Countries citing papers authored by Jami McLaughlin
This map shows the geographic impact of Jami McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jami McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jami McLaughlin more than expected).
Fields of papers citing papers by Jami McLaughlin
This network shows the impact of papers produced by Jami McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jami McLaughlin. The network helps show where Jami McLaughlin may publish in the future.
Co-authorship network of co-authors of Jami McLaughlin
This figure shows the co-authorship network connecting the top 25 collaborators of Jami McLaughlin. A scholar is included among the top collaborators of Jami McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jami McLaughlin. Jami McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 8 | |
| 3 | 1 | |
| 4 | 29 | |
| 5 | 22 | |
| 6 | 81 | |
| 7 | 38 | |
| 8 | 79 | |
| 9 | 54 | |
| 10 | 55 | |
| 11 | 9 | |
| 12 | 67 | |
| 13 | 217 | |
| 14 | 162 | |
| 15 | 221 | |
| 16 | 45 | |
| 17 | 10 | |
| 18 | 29 | |
| 19 | 205 | |
| 20 | 279 |
About Jami McLaughlin
Jami McLaughlin is a scholar working on Hematology, Genetics and Oncology, having authored 32 papers that have together received 2.8k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (17 papers), Chronic Lymphocytic Leukemia Research (8 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (768 citations) and Immunology (546 citations). Jami McLaughlin has collaborated with scholars based in United States, Australia and Poland. Frequent co-authors include Owen N. Witte, Daniel Afar, Andrei Goga, Charles L. Sawyers, Steven S. Clark, William M. Crist, Caius G. Radu, Irvin S. Y. Chen, David W. Golde and Richard E. Champlin. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.